Some gene therapies no longer require clinical trials, thanks to new FDA rule. Is this safe, and who will it help?

0
108

The Food and Drug Administration (FDA) is implementing a new strategy to provide experimental gene therapies to patients with rare disorders without going through clinical trials. This framework could grant these patients access to individualized therapies, but experts are divided over whether the regulatory change is safe enough for patients.

Dr. Senthil Bhoopalan, a genome-editing expert at St. Jude’s Children Research Hospital in Tennessee, said that, although the framework is still emerging and the details require more discussion between the public and stakeholders, “it’s an exciting step in the right direction.”

Read more…

LEAVE A REPLY

Please enter your comment!
Please enter your name here